Riskpilot← Back to searchSign inGet full accessDyreklinikken Ebeltoft ApS
APSActiveCVR 42055379A. Knudsens Vej 10Veterinary activities · NACE 7500Est. 20218 employees
Revenue 2025
DKK 3,3M
+21% vs 2024
EBITDA margin
20.1%
+58% vs 2024
Equity ratio
17.8%
Financial strength
Net profit 2025
DKK 296K
+199% vs 2024
| Revenue | DKK 3,3M | +21% |
| EBITDA | DKK 662K | +58% |
| Net profit | DKK 296K | +199% |
| Total assets | DKK 2,5M | +22% |
| Equity | DKK 444K | +79% |
| Employees | 8 | — |
Legal name
Dyreklinikken Ebeltoft ApS
CVR number
42055379
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
25. januar 2021
Share capital
DKK 40.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen.
Company purpose
at drive drive almen dyrelægepraksis og dermed beslægtet virksomhed
Address
A. Knudsens Vej 10
Phone
+4586344459
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.011 | 1.574 | 2.143 | 2.729 | 3.299 |
| Staff expenses | -794 | -1.254 | -1.725 | -2.311 | -2.636 |
| EBITDA | 217 | 320 | 418 | 418 | 662 |
| Depreciation & amort. | -73 | -160 | -197 | -209 | -209 |
| EBIT | 144 | 160 | 220 | 209 | 453 |
| Net financials | -26 | -44 | -58 | -62 | -71 |
| Profit before tax | 117 | 117 | 163 | 147 | 382 |
| Tax | 27 | 26 | 36 | 48 | 85 |
| Net profit | 90 | 91 | 127 | 99 | 296 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.385 | 1.782 | 2.166 | 2.044 | 2.490 |
| Equity | 130 | 221 | 348 | 247 | 444 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.240 | 1.534 | 1.790 | 1.768 | 2.018 |
| Total debt | 1.240 | 1.534 | 1.790 | 1.768 | 2.018 |
EBITDA margin
20.1%
This company
15.8%
Market median
+27% vs market
20212025
Equity ratio
17.8%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
66.8%
This company
18.4%
Market median
+263% vs market
20212025
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20212025
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
4.61×
This company
0.62×
Market median
-644% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2021-01-25 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JA Management | Management | 2023 |
JT Management | Management | 2021 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2023 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JT Holding Ebeltoft ApS
Dyreklinikken Ebeltoft ApS Board members of Dyreklinikken Ebeltoft ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jake Alexander Bernau Urban | Management | 0 companies |
| Jens Tvilum | Management | 0 companies |